JMJD1C anticorps (AA 150-200)
Aperçu rapide pour JMJD1C anticorps (AA 150-200) (ABIN1906272)
Antigène
Voir toutes JMJD1C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 150-200
-
Specificité
- Region between residue 150 and 200 of human Jumonji Domain Containing 1C using the numbering given in entry NP_004232.2 (GeneID 221037).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:500 - 1:2500), IHC, IHC-P (1:1000 - 1:5000), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Laryngeal Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Ovarian Carcinoma, Skin Squamous Cell Carcinoma.
Not recommended for: IP -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- JMJD1C (Jumonji Domain Containing 1C (JMJD1C))
-
Autre désignation
- JMJD1C
-
Sujet
-
Name/Gene ID: JMJD1C
Synonyms: JMJD1C, JHDM2C, Jumonji domain containing 1C, KIAA1380, TR-interacting protein 8, TRIP-8, RP11-10C13.2, TRIP8 -
ID gène
- 221037
-
Pathways
- Nuclear Hormone Receptor Binding
Antigène
-